These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3158905)

  • 1. [Fatal massive intravascular coagulation during phlebography. Responsibility of epsilon-aminocaproic acid?].
    Coste F; Tremolières F; Bousquet M; Martin E; Dreyfuss D; Levesque M; Barge J
    Presse Med; 1985 Apr; 14(15):832-4. PubMed ID: 3158905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases.
    MacKay AR; Sang U H; Weinstein PR
    J Neurosurg; 1978 Oct; 49(4):597-601. PubMed ID: 690689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive thrombosis following central venous catheterization--a relationship to antifibrinolytic therapy?
    Hayhurst MD
    S Afr Med J; 1983 May; 63(21):797. PubMed ID: 6845102
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report.
    Tubbs RR; Benjamin SP; Dohn DE
    J Neurosurg; 1979 Jul; 51(1):94-7. PubMed ID: 448423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myopathy induced by epsilon-aminocaproic acid. Case report.
    Brown JA; Wollmann RL; Mullan S
    J Neurosurg; 1982 Jul; 57(1):130-4. PubMed ID: 7086489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhabdomyolysis during treatment with epsilon-aminocaproic acid.
    Britt CW; Light RR; Peters BH; Schochet SS
    Arch Neurol; 1980 Mar; 37(3):187-8. PubMed ID: 7356431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral sinus thrombosis as a potential hazard of antifibrinolytic treatment in menorrhagia.
    Achiron A; Gornish M; Melamed E
    Stroke; 1990 May; 21(5):817-9. PubMed ID: 2339463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstruction of solitary kidney due to epsilon-aminocaproic-acid-induced fibrin clot formation.
    Geltzeiler J; Schwartz D
    Urology; 1984 Jul; 24(1):64-6. PubMed ID: 6740850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purpuric rash due to epsilon-aminocaproic acid.
    Chakrabarti A; Collett KA
    Br Med J; 1980 Jul; 281(6234):197-8. PubMed ID: 6447530
    [No Abstract]   [Full Text] [Related]  

  • 10. Safe and effective, prolonged administration of epsilon aminocaproic acid in bleeding from the urinary tract.
    Stefanini M; English HA; Taylor AE
    J Urol; 1990 Mar; 143(3):559-61. PubMed ID: 2304169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myoglobinuria following epsilon-aminocaproic acid (EACA) therapy. Case report.
    Brodkin HM
    J Neurosurg; 1980 Nov; 53(5):690-2. PubMed ID: 7431078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute renal failure due to high-grade obstruction following therapy with epsilon-aminocaproic acid.
    Pitts TO; Spero JA; Bontempo FA; Greenberg A
    Am J Kidney Dis; 1986 Dec; 8(6):441-4. PubMed ID: 3812474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epsilon-aminocaproic acid in the reversal of consumptive coagulopathy with platelet sequestration in a vascular malformation of Klippel-Trenaunay syndrome.
    Poon MC; Kloiber R; Birdsell DC
    Am J Med; 1989 Aug; 87(2):211-3. PubMed ID: 2547315
    [No Abstract]   [Full Text] [Related]  

  • 14. Epsilon-aminocaproic acid myopathy. Report of a case and literature review.
    Vanneste JA; van Wijngaarden GK
    Eur Neurol; 1982; 21(4):242-8. PubMed ID: 7117311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ejaculation due to epsilon aminocaproic acid.
    Evans BE; Aledort LM
    N Engl J Med; 1978 Jan; 298(3):166-7. PubMed ID: 619254
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute delirious state after epsilon-aminocaproic acid.
    Wysenbeek AJ; Sella A; Vardi M; Yeshurun D
    Lancet; 1978 Jan; 1(8057):221. PubMed ID: 74653
    [No Abstract]   [Full Text] [Related]  

  • 17. Epsilon-aminocaproic acid-induced myopathy. A case report.
    Morris CD; Jacobs P; Berman PA; Rutherfoord GS
    S Afr Med J; 1983 Sep; 64(10):363-6. PubMed ID: 6612533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic contact dermatitis from epsilon-aminocaproic acid.
    Shono M
    Contact Dermatitis; 1989 Aug; 21(2):106-7. PubMed ID: 2530047
    [No Abstract]   [Full Text] [Related]  

  • 19. Myonecrosis complicating epsilon aminocaproic acid treatment of traumatic haematuria.
    Johnstone BR; Syme RR
    Br J Urol; 1987 Jul; 60(1):81-2. PubMed ID: 3620853
    [No Abstract]   [Full Text] [Related]  

  • 20. Epsilon aminocaproic acid (EACA) myopathy.
    Lane RJ; McLelland NJ; Martin AM; Mastaglia FL
    Postgrad Med J; 1979; 55(642):282-5. PubMed ID: 471867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.